SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay
Primo N. Lara, James Moon, Paul J. Hesketh, Mary W. Redman, Stephen K. Williamson, Wallace L. Akerley, Fred R. Hirsch, Philip C. Mack, David R. Gandara
Research output: Contribution to journal › Article › peer-review
13Scopus
citations
Fingerprint
Dive into the research topics of 'SWOG S0709: Randomized phase II trial of erlotinib versus erlotinib plus carboplatin/paclitaxel in patients with advanced non-small cell lung cancer and impaired performance status as selected by a serum proteomics assay'. Together they form a unique fingerprint.